| Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
|---|
| 01/29/2003 | EP1278723A2 P-(sulfonyl)-aryl and -heteroaryl amines |
| 01/29/2003 | EP0973735B1 Polyaromatic antiviral compositions |
| 01/28/2003 | US6512020 Oxime derivatives and the use thereof as latent acids |
| 01/28/2003 | CA2124375C Compounds containing a fused bicyclic ring and processes therefor |
| 01/27/2003 | WO2002010127A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia |
| 01/27/2003 | CA2417427A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia |
| 01/24/2003 | WO2002010145A1 Urethane derivatives |
| 01/24/2003 | CA2417268A1 Urethane derivatives |
| 01/23/2003 | WO2003006425A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/23/2003 | WO2003006424A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/23/2003 | WO2003006021A1 Alpha-hydroxyamide statine derivatives for the treatment of alzh eimer's disease |
| 01/23/2003 | US20030018207 Pharmaceutical medication associated with insulin resistance; patient with prophylaxis conditions having reduced sensitivity to insulin |
| 01/23/2003 | US20030018200 Preparation of isoxazolin-3-ylacylbenzenes |
| 01/23/2003 | US20030018016 Cell adhesion inhibitors |
| 01/23/2003 | US20030017964 Administration of agents via the PEPT-2 transporter |
| 01/23/2003 | CA2453447A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 01/23/2003 | CA2452491A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/22/2003 | EP1277727A1 Process for producing bis(4-hydroxy-3-nitrophenyl) compound |
| 01/22/2003 | EP1277726A1 Process for the preparation of 2-halobenzoic acids |
| 01/22/2003 | EP1276736A2 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes |
| 01/22/2003 | EP1034159B1 Process for the preparation of acylated cyclic 1,3-dicarbonyl compounds |
| 01/21/2003 | US6509499 Nervous system disorders, vision defects, diabetic retinopathy, neuropathic pain and kidney disorder treatment |
| 01/21/2003 | US6509369 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 01/21/2003 | US6509354 3-arylphenyl sulfide derivative and insecticide and miticide |
| 01/16/2003 | WO2002076930A3 Substituted diarylureas as stimulators for fas-mediated apoptosis |
| 01/16/2003 | WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
| 01/16/2003 | US20030013760 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/16/2003 | US20030013748 Anticancer agents |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013713 Compounds as PDE IV and TNF-inhibitors |
| 01/16/2003 | US20030013702 Agents and methods for treatment of cancer |
| 01/16/2003 | US20030012803 E.g., ethyl 3-methyl-5-(,5,8,8-tetra-methyl-5,6,7,8-tetra-hydronaphthalen-2 -ylselenyl)pent-2-en-4-ynoate; dermatological, rheumatic, respiratory, cardiovascular and ophthalmological uses as well as cosmetic uses |
| 01/15/2003 | EP1275635A1 Calcium receptor-active compounds |
| 01/15/2003 | EP1274679A1 Bifunctional inhibitors of malarial proteases and uses thereof |
| 01/15/2003 | EP1274424A1 Compounds and methods |
| 01/15/2003 | EP1060200B1 Substantially fluorinated ionomers |
| 01/15/2003 | EP0912572B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391555A Benzamides and related inhibitors of factor Xa |
| 01/14/2003 | US6506936 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 01/14/2003 | US6506934 Compounds particularly useful as antifoggants in silver halide photographic materials |
| 01/14/2003 | US6506800 For control of insect and acarid pests |
| 01/14/2003 | US6506780 Benzophenones and sulfones as inhibitors of glycine uptake |
| 01/14/2003 | US6506778 Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals |
| 01/14/2003 | US6506733 Compounds and compositions as protease inhibitors |
| 01/14/2003 | US6506517 Surface modified carbonaceous materials |
| 01/09/2003 | WO2003002526A1 Method of oxidizing an alcohol using a recyclable fluorous sulfoxide |
| 01/09/2003 | WO2003002524A2 Urea derivatives with antiproteolytic activity |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2001068637A3 Method for the preparation of tetrahydrobenzothiepines |
| 01/09/2003 | US20030008881 Substituted phenylcyclohexanecarboxamides and their use |
| 01/08/2003 | EP1273570A1 Process for producing diphenyl sulfone compound |
| 01/08/2003 | EP1272462A1 Semi-continuous method for producing 4,4'-dihydroxydiphenylsulfone |
| 01/08/2003 | EP1023266B1 Process for making diaryl pyridines useful as cox-2 inhibitors |
| 01/08/2003 | CN1390206A Inhibitors of factor Xa |
| 01/08/2003 | CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1389458A P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/03/2003 | WO2002056915A3 Complex of modafinil and cyclodextrin |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | EP1270565A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives |
| 01/02/2003 | EP1270554A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 01/02/2003 | EP1270551A1 Urea derivatives with antiproteolytic activity |
| 01/02/2003 | EP1269979A1 Aromatic amide, sulfonamide or carbamate acrylonitrile derivatives and photoprotective cosmetic compositions containing them |
| 01/02/2003 | EP1268414A1 Ceramide derivatives and method of use |
| 01/02/2003 | EP1268413A2 Substituted biphenyl derivatives |
| 01/02/2003 | EP1268404A1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2003 | EP1268396A1 Diphenyl ether compounds useful in therapy |
| 01/02/2003 | EP1115716B1 2-phenylpyran-4-one derivatives |
| 01/01/2003 | CN1388117A Process for prodcing 3-aryl sulfate iso-hydroximic acid |
| 12/31/2002 | USRE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/27/2002 | WO2002072540A3 Improved methods of ortho alkylation |
| 12/26/2002 | US20020198388 Sulfonamides which are aspartyl protease inhibitors; well suited for inhibiting HIV-1 and HIV-2 protease activity |
| 12/26/2002 | US20020198376 As therapeutic agents for autoimmune diseases such as rheumatoid arthritis |
| 12/26/2002 | US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/26/2002 | US20020198245 Heterocyclic aromatic oxazole compounds and use thereof |
| 12/26/2002 | US20020198244 Heterocyclic aromatic oxazole compounds and use thereof |
| 12/26/2002 | US20020198236 Small organic molecule regulators of cell proliferation |
| 12/26/2002 | US20020198200 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 12/25/2002 | CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 12/24/2002 | US6498180 Such as 2-(3'-hydroxymethyl-2'-carboxycyclopropyl)glycine; modulating metabotropic glutamate receptor; treating disorders of central nervous |
| 12/24/2002 | US6498004 Silver halide light sensitive emulsion layer having enhanced photographic sensitivity |
| 12/19/2002 | WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/19/2002 | WO2002100812A1 Carboxylic acid derivative and salt thereof |
| 12/19/2002 | WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/19/2002 | WO2002100339A2 Novel process for preparing rac-bicalutamide and its intermediates |
| 12/19/2002 | WO2002100172A1 Administration of agents via the pept-2 transporter |
| 12/19/2002 | WO2002042248A3 Naphthalene derivatives |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/19/2002 | US20020193540 Ionically conducting materials, electrolytes and selective membranes |
| 12/19/2002 | US20020193515 Polarization film containing a monoazo compound or salt |
| 12/19/2002 | US20020193414 Adamantane derivatives |
| 12/19/2002 | US20020193239 For use as catalysts in epoxidation of olefins, for oxidation of alcohols, oxidation of organic thiols; hydroxylation of aromatic compounds; ammoximation of ketones |
| 12/19/2002 | CA2448571A1 Novel process for preparing rac-bicalutamide and its intermediates |